| TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti–PD-1 tumor immunotherapy B Di Luccia, M Molgora, D Khantakova, N Jaeger, HW Chang, ... Science immunology 9 (95), eadi5374, 2024 | | 2024 |
| Inositol phosphatase INPP4B sustains ILC1s and intratumoral NK cells through an AKT-driven pathway V Peng, T Trsan, R Sudan, B Bhattarai, VS Cortez, M Molgora, J Vacher, ... Journal of Experimental Medicine 221 (3), e20230124, 2024 | 2 | 2024 |
| A Cre-deleter specific for embryo-derived brain macrophages reveals distinct features of microglia and border macrophages S Brioschi, JA Belk, V Peng, M Molgora, PF Rodrigues, KM Nguyen, ... Immunity 56 (5), 1027-1045. e8, 2023 | 21 | 2023 |
| TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer MD Park, I Reyes-Torres, J LeBerichel, P Hamon, NM LaMarche, ... Nature immunology 24 (5), 792-801, 2023 | 50 | 2023 |
| TREM2: A new player in the tumor microenvironment M Molgora, YA Liu, M Colonna, M Cella Seminars in immunology 67, 101739, 2023 | 8 | 2023 |
| EXTH-60. ONCR-GBM, A NOVEL ARMED ONCOLYTIC HSV-1 VECTOR ENGINEERED FOR EFFICACY AND SAFETY IN GLIOBLASTOMA C Strathdee, F Giovannoni, M Molgora, L Kong, M Floyd, J Teng, ... Neuro-Oncology 24 (Suppl 7), vii223, 2022 | 1 | 2022 |
| 833 Blockade of human LILRB4/ILT3 inhibits the formation of lung metastasis in melanoma model D Khantakova, M Molgora, J Roda, G Stone, S Gilfillan, T Trsan, M Cella, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Interleukin 1 Receptor 8 Deficiency Does not Impact Atherosclerosis J Nour, A Moregola, M Molgora, A Mantovani, P Uboldi, AL Catapano, ... Thrombosis and haemostasis 122 (10), 1833-1836, 2022 | | 2022 |
| Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer E Timperi, P Gueguen, M Molgora, I Magagna, Y Kieffer, S Lopez-Lastra, ... Cancer research 82 (18), 3291-3306, 2022 | 92 | 2022 |
| Innate-like T cells: A promising asset in anti-cancer immunity M Molgora, M Colonna Cancer cell 40 (7), 714-716, 2022 | 5 | 2022 |
| TREM2+ macrophages mediate immunosuppression in tumors M Molgora, BD Luccia, D Khantakova, N Jaeger, RS Czepielewski, ... Cancer Research 82 (12_Supplement), 3615-3615, 2022 | | 2022 |
| Exploring the impact of TREM2 in tumor-associated macrophages D Khantakova, S Brioschi, M Molgora Vaccines 10 (6), 943, 2022 | 27 | 2022 |
| The fibronectin–ILT3 interaction functions as a stromal checkpoint that suppresses myeloid cells KJ Paavola, JM Roda, VY Lin, P Chen, KP O'Hollaren, R Ventura, ... Cancer immunology research 9 (11), 1283-1297, 2021 | 31 | 2021 |
| Turning enemies into allies—Reprogramming tumor-associated macrophages for cancer therapy M Molgora, M Colonna Med 2 (6), 666-681, 2021 | 30 | 2021 |
| Killing the invaders: NK cell impact in tumors and anti-tumor therapy M Molgora, VS Cortez, M Colonna Cancers 13 (4), 595, 2021 | 28 | 2021 |
| Killing the Invaders: NK Cell Impact in Tumors and Anti-Tumor Therapy. Cancers 2021, 13, 595 M Molgora, VS Cortez, M Colonna s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| Nk or t cells and uses thereof A Mantovani, M Molgora, C Garlanda, E Bonavita US Patent App. 16/758,136, 2020 | 2 | 2020 |
| TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy M Molgora, E Esaulova, W Vermi, J Hou, Y Chen, J Luo, S Brioschi, ... Cell 182 (4), 886-900. e17, 2020 | 396 | 2020 |
| Single-cell sequencing of mouse heart immune infiltrate in pressure overload–driven heart failure reveals extent of immune activation E Martini, P Kunderfranco, C Peano, P Carullo, M Cremonesi, T Schorn, ... Circulation 140 (25), 2089-2107, 2019 | 248 | 2019 |
| Pentraxin 3 deficiency protects from the metabolic inflammation associated to diet-induced obesity F Bonacina, A Moregola, R Porte, A Baragetti, E Bonavita, A Salatin, ... Cardiovascular Research 115 (13), 1861-1872, 2019 | 39 | 2019 |
